The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Palatin Technologies, Inc(NYSE MKT:PTN) 
Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acqui...
Website: http://www.palatin.com
Founded: 1986
Full Time Employees: 20
Sector: Healthcare
Industry: Biotechnology
Palatin Technologies Days Payable Outstanding ttm (DPO)
Palatin Technologies Days Receivable Outstanding ttm (DSO)
Palatin Technologies Days Inventory Outstanding ttm (DIO)
Palatin Technologies Op Cashflow Per Share ttm
Palatin Technologies Free Cashflow Per Share ttm
Palatin Technologies Cash Per Share ttm
Palatin Technologies P/S ratio ttm
Palatin Technologies (GAAP) P/E ratio ttm
Palatin Technologies P/B ratio ttm
No extra charts and metrics for this ticker.